Effect of combined exercise training in pediatric type 1 diabetes

Effect of combined exercise training on inflammatory factors and levels of hormones associated with blood glucose homeostasis in pediatric type 1 diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150531022498N30

Enrollment

Registered

2019-07-26

Start date

2019-02-09

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 diabetes. Type 1 diabetes mellitus

Interventions

Intervention 1: Intervention group: Combined training group. Aerobic training: sixteen weeks, three times per week . Aerobic exercises were performed with an intensity of 50-75% of maximum heart rate

Eligibility

Sex/Gender

All

Age

8 Years to 15 Years

Inclusion criteria

Inclusion criteria: Having age ranges of 8-15 years A1c=7 Pediatric type 1 diabetes No regular exercise

Exclusion criteria

Exclusion criteria: More than three session absence from the training

Design outcomes

Primary

Measure	Time frame
IL-1B. Timepoint: Before and after the end of interventions. Method of measurement: using ELISA Kit.;High-sensitivity C-reactive Protein (hs-CRP). Timepoint: Before and after the end of interventions. Method of measurement: using ELISA Kit.;IGF-1. Timepoint: Before and after the end of interventions. Method of measurement: using ELISA Kit.;Growth hormone. Timepoint: Before and after the end of interventions. Method of measurement: using ELISA Kit.;Cortisol. Timepoint: Before and after the end of interventions. Method of measurement: using ELISA Kit.;HbA1c. Timepoint: Before and after the end of interventions. Method of measurement: using ELISA Kit.;Fast blood sugar. Timepoint: Before and after the end of interventions. Method of measurement: using ELISA Kit.;Complete Blood Count (CBC). Timepoint: Before and after the end of interventions. Method of measurement: using ELISA Kit.	—

Measure

Time frame

IL-1B. Timepoint: Before and after the end of interventions. Method of measurement: using ELISA Kit.;High-sensitivity C-reactive Protein (hs-CRP). Timepoint: Before and after the end of interventions. Method of measurement: using ELISA Kit.;IGF-1. Timepoint: Before and after the end of interventions. Method of measurement: using ELISA Kit.;Growth hormone. Timepoint: Before and after the end of interventions. Method of measurement: using ELISA Kit.;Cortisol. Timepoint: Before and after the end of interventions. Method of measurement: using ELISA Kit.;HbA1c. Timepoint: Before and after the end of interventions. Method of measurement: using ELISA Kit.;Fast blood sugar. Timepoint: Before and after the end of interventions. Method of measurement: using ELISA Kit.;Complete Blood Count (CBC). Timepoint: Before and after the end of interventions. Method of measurement: using ELISA Kit.

—

Secondary

Measure	Time frame
Quality of Life. Timepoint: Before and after the end of interventions. Method of measurement: Using questionnaire.;Body composition. Timepoint: Before and after the end of interventions. Method of measurement: Using weight, body mass index, waist to hip ratio and fat percent.;Physical fitness. Timepoint: Before and after the end of interventions. Method of measurement: Using measurement of aerobic power ,anaerobic , balance ,Flexibility and hand grip.;Blood pressure. Timepoint: Before and after the end of interventions. Method of measurement: Using the blood pressure device.	—

Measure

Time frame

Quality of Life. Timepoint: Before and after the end of interventions. Method of measurement: Using questionnaire.;Body composition. Timepoint: Before and after the end of interventions. Method of measurement: Using weight, body mass index, waist to hip ratio and fat percent.;Physical fitness. Timepoint: Before and after the end of interventions. Method of measurement: Using measurement of aerobic power ,anaerobic , balance ,Flexibility and hand grip.;Blood pressure. Timepoint: Before and after the end of interventions. Method of measurement: Using the blood pressure device.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarzieh Nazari

Islamic Azad University

marzieh.nazari.v@gmail.com+98 13 3342 2153

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 10, 2026